4 Must-Do Professional Prelaunch Tactics
Have you ever heard of Product Manager’s Disease? It’s when a Product Manager or Product Director attempts to execute as many tactics as possible without truly thinking through which tactics make the most sense for a given audience at a particular time. In other words, it’s throwing everything at the
How to Fortify Your Brand Messaging
Branding your peer-to-peer programs is more than just creating a logo or developing a marketing strategy—although marketing and branding are closely related, they are often confused. Marketing includes all of the commercial activities that are required to gain acceptance of your brand in the marketplace. Branding peer-to-peer programs is the
How Price Controls Could Plug the New Product Pipeline
Regulated pharmaceutical prices are common in foreign countries, but the United States government has been reluctant to set pharmaceutical price ceilings. A recent online poll conducted by Pharmaceutical Executive asked its audience, which consists primarily of professionals working in the pharmaceutical industry, what their greatest concern is for the future of the
Vision2Voice Recieves the 2014 BBB Integrity Award
OMAHA, NE – October 7, 2014 – Vision2Voice was awarded the 2014 Better Business Bureau Integrity Award in Omaha, NE at the Embassy Suites in Omaha –La Vista Conference Center on Tuesday, October 7, 2014. These awards focus on demonstrated ethical business practices with key stakeholders including customers, employees, and
Protected: Conquering the Whirlwind
There is no excerpt because this is a protected post.
The Future of Big Pharma: Preventative Medicine?
Rising healthcare costs in the United States have caused government, corporate, and association leaders to look for ways to make our healthcare system more efficient. Insurance provider and Affordable Care Act plans both provide for preventative care in order to keep long term costs down for the patient and the
Wait, the Doctor-Patient Conversation?
In pharma marketing, messaging and targeting are everything. The most appropriate words delivered to a carefully selected group of healthcare professionals leads to patients getting the best treatments. Or does it? When listening to patients and physicians separately, we often get different answers. Asking a patient how a diagnosis was delivered
Simplifying Oncology: Incorporate KOLS
The last decade has brought a variety of innovative cancer treatment options to the market. A 2009 study conducted by PhRMA compiled a list of 129 medications in development to treat Leukemia, 122 to treat lung cancer, and 106 to treat breast cancer[1]. The number of oncology patients has steadily grown
